北美癌症唾液检测设备市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美癌症唾液检测设备市场 – 行业趋势及 2028 年预测

  • Healthcare
  • Published Report
  • Aug 2021
  • North America
  • 350 页面
  • 桌子數: 78
  • 图号: 49

北美癌症唾液测试设备市场,按产品类型(唾液收集套件、液体专用设备、口腔拭子、条形码标签、唾液冷冻保存盒等)、收集部位(下颌下腺/舌下腺、腮腺和小唾液腺)、应用(肝肺癌、乳腺癌、结肠和直肠癌、前列腺癌、胰腺癌、口腔癌、甲状腺癌、子宫内膜癌、肾癌、白血病、黑色素瘤、非霍奇金淋巴瘤等)、年龄组(成人和儿科)、收集方法(被动口水、口腔拭子等)、最终用户(医院、诊断实验室、肿瘤专科诊所、癌症研究机构等)、分销渠道(直接招标、零售等)国家(美国、加拿大和墨西哥)行业趋势和预测到 2028 年。

北美癌症唾液测试设备市场市场分析和洞察:北美癌症唾液测试设备市场

北美癌症唾液测试设备市场预计将在 2021 年至 2028 年的预测期内实现显着增长。Data Bridge Market Research 分析,北美癌症唾液测试设备市场在 2021 年至 2028 年的预测期内以 10.0% 的复合年增长率增长,预计将从 2020 年的 2.3006 亿美元达到 2028 年的 4.7328 亿美元。慢性病患病率的上升和癌症患者的增加是主要驱动因素,预计将在预测期内推动市场的增长。

唾液测试广泛用于癌症检测。癌症唾液可以检测是否存在突变的细胞外 DNA 和 RNA。肿瘤细胞会将 DNA 和 RNA 释放到血液循环中,然后进入唾液,因此可以非常准确地在唾液中检测到突变。

癌症唾液检测设备市场包括用于检测人类药物、感染或疾病的检测试剂盒、拭子、盒式磁带和设备。多种类型的试剂盒利用不同类型的分子生物学方法进行疾病检测。ELISA、PCR 免疫测定和酶促测定等是用于唾液检测的分子技术。

北美癌症唾液检测设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报,我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。   

北美癌症唾液测试设备市场北美癌症唾液测试设备市场范围和市场规模

北美癌症唾液检测设备市场根据产品类型、采集地点、应用、年龄组、采集方法、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据产品类型,北美癌症唾液检测设备市场细分为唾液收集套件、液体专用设备、口腔拭子、条形码标签、唾液冷冻保存盒等。2021 年,由于对 POCT 设备的需求不断增加以及该地区癌症患者患病率不断上升,唾液收集套件细分市场预计将占据市场主导地位。
  • 根据采集部位,北美癌症唾液检测设备市场分为颌下腺/舌下腺、腮腺和小唾液腺。2021 年,由于癌症患者数量激增和医疗支出增加,预计颌下腺/舌下腺将占据市场主导地位。
  • 根据应用,北美癌症唾液检测设备市场细分为肝肺癌、乳腺癌、结肠和直肠癌、前列腺癌、胰腺癌、口腔癌、甲状腺癌、子宫内膜癌、肾癌、白血病、黑色素瘤、非霍奇金淋巴瘤等。2021 年,由于生活方式的改变和肝硬化发病率的上升,肝肺癌领域预计将占据市场主导地位。
  • 根据年龄组,北美癌症唾液检测设备市场分为成人和儿科。2021 年,由于该地区老年人口增加和慢性病患病率上升,成人市场预计将占据市场主导地位。
  • 根据采集方法,北美癌症唾液检测设备市场分为被动唾液、口腔拭子和其他。2021 年,被动唾液部分预计将占据市场主导地位,因为它的存储和收集更符合患者的依从性。
  • 根据最终用户,北美癌症唾液检测设备市场分为医院、诊断实验室、肿瘤专科诊所、癌症研究机构等。2021 年,由于人们对癌症及其治疗的认识不断提高,预计医院将占据市场主导地位。
  • 根据分销渠道,北美癌症唾液检测设备市场分为直接招标、零售和其他。2021 年,由于医疗保健支出增加和产品易于获得,预计直销部门将占据市场主导地位。

北美癌症唾液测试设备市场国家级分析

对北美癌症唾液测试设备市场进行分析,并根据产品类型、收集地点、应用、年龄组、收集方法、最终用户和分销渠道提供市场规模信息。

北美癌症唾液检测设备市场报告涵盖的国家包括美国、加拿大和墨西哥。由于该地区慢性病患病率不断上升,北美预计将主导癌症唾液检测设备市场。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。  

医疗支出的上涨和癌症的高发性为北美癌症唾液检测设备市场参与者创造了新的机遇

由于美国癌症发病率上升,美国唾液收集试剂盒市场预计将以最高速度增长,并在 2021 年至 2028 年的预测期内主导北美地区。

北美癌症唾液测试设备市场还为您提供每个国家/地区特定行业增长的详细市场分析,包括北美癌症唾液测试设备市场销售、北美癌症唾液测试设备市场发展的影响以及监管环境的变化及其对北美癌症唾液测试设备市场的支持。数据涵盖 2010 年至 2018 年的历史时期。 

竞争格局和北美癌症唾液测试设备市场份额分析

北美癌症唾液测试设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和宽度、应用优势和技术生命线曲线。以上提供的数据点仅与公司对北美癌症唾液测试设备市场的关注有关。

报告中涉及的主要参与者包括 DNA Genotek、Salimetrics、LLC、PeriRx、Color Health、Inc.、SARSTEDT AG. Co. KG、Miraclean Technology Co.、Ltd.、Agilent Technologies、Inc.、Illumina、Inc.、QIAGEN、Thermo Fisher Scientific Inc.、Abbott、BD、Biocartis、bioMérieux SA、Siemens Healthcare GmbH、F. Hoffmann-La Roche Ltd、Oasis Diagnostics Corporation、Canvax(dobuss 的子公司)以及其他国内和北美参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地的公司也发起了许多产品发布和协议,进一步加速了北美癌症唾液测试设备市场的增长。

例如,

  • 2021 年 1 月,DNA Genotek 宣布美国食品药品监督管理局 (FDA) 已授予其 OrageneDx 系列产品的通用 510(k) 许可。FDA 的此项批准提高了该公司在市场上的信誉,并增加了对该产品的需求。
  • 2021 年 2 月,赛默飞世尔科技荣获六项 CMO 领导力奖。该公司在能力、兼容性、专业知识、质量、可靠性和服务等所有六个类别中均获奖。这是赛默飞世尔科技连续第二年在所有六个类别中获得这一认可,也是该公司第八次获得 CMO 领导力奖。这提高了公司的信誉并有助于增加收入。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CANCER SPIT TEST DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATORY FRAMEWORKS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN CANCER BURDEN WORLDWIDE

6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS

6.1.3 RISE IN GERIATRIC POPULATION

6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER

6.1.5 RISE IN EXPENDITURE ON HEALTHCARE

6.2 RESTRAINTS

6.2.1 INCREASE PREVALENCE OF COVID-19

6.2.2 LACK OF EARLY DETECTION

6.3 OPPORTUNITIES

6.3.1 RECOMMENDATIONS FOR CANCER SCREENING

6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING

6.3.3 RISE IN R&D ACTIVITIES

6.4 CHALLENGES

6.4.1 STRINGENT REGULATION POLICY

6.4.2 RISING COMPETITION AMONG MARKET PLAYERS

7 IMPACT OF COVID-19 THE ON NORTH AMERICA CANCER SPIT TEST DEVICES MARKET

7.1 IMPACT ON SUPPLY CHAIN

7.2 IMPACT ON DEMAND

7.3 STRATEGIC DECISIONS FOR MANUFACTURERS

7.4 CONCLUSION

8 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 SALIVA COLLECTION KIT

8.2.1 DNA EXTRACT

8.2.2 RNA EXTRACT

8.3 FLUID SPECIFIC DEVICES

8.4 ORAL SWAB

8.5 BAR-CODE LABELS

8.6 SALIVA CRYOSTORAGE BOX

8.7 OTHERS

9 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION

9.1 OVERVIEW

9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND

9.3 PAROTID GLAND

9.4 MINOR SALIVARY GLAND

10 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 LIVER-LUNG CANCER

10.3 BREAST CANCER

10.4 COLON AND RECTAL CANCER

10.5 PROSTATE CANCER

10.6 PANCREATIC CANCER

10.7 ORAL CANCER

10.8 THYROID CANCER

10.9 ENDOMETRIAL CANCER

10.1 KIDNEY CANCER

10.11 LEUKEMIA

10.12 MELANOMA

10.13 NON-HODGKIN LYMPHOMA

10.14 OTHERS

11 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP

11.1 OVERVIEW

11.2 ADULT

11.3 PEDIATRICS

12 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION

12.1 OVERVIEW

12.2 PASSIVE DROOL

12.3 ORAL SWAB

12.4 OTHERS

13 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 DIAGNOSTIC LABORATORIES

13.4 ONCOLOGY SPECIALITY CLINICS

13.5 CANCER RESEARCH INSTITUTES

13.6 OTHERS

14 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT TENDER

14.3 RETAIL SALES

14.4 OTHERS

15 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY REGION

15.1 NORTH AMERICA

15.1.1 U.S.

15.1.2 CANADA

15.1.3 MEXICO

16 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 BIOCARTIS

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 BD

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENT

18.3 ABBOTT

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENT

18.4 F. HOFFMANN-LA ROCHE LTD

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENT

18.5 QIAGEN

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 AGILENT TECHNOLOGIES, INC.

18.6.1 COMPANY SNAPSHOT

18.6.2 REVENUE ANALYSIS

18.6.3 PRODUCT PORTFOLIO

18.6.4 RECENT DEVELOPMENTS

18.7 BIOMÉRIEUX SA

18.7.1 COMPANY SNAPSHOT

18.7.2 REVENUE ANALYSIS

18.7.3 PRODUCT PORTFOLIO

18.7.4 RECENT DEVELOPMENT

18.8 CANVAX

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

18.9 COLOR HEALTH, INC.

18.9.1 1.6.1 COMPANY SNAPSHOT

18.9.2 1.6.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.1 DNA GENOTEK

18.10.1 COMPANY SNAPSHOT

18.10.2 REVENUE ANALYSIS

18.10.3 PRODUCT PORTFOLIO

18.10.4 RECENT DEVELOPMENT

18.11 ILLUMINA, INC.

18.11.1 COMPANY SNAPSHOT

18.11.2 REVENUE ANALYSIS

18.11.3 PRODUCT PORTFOLIO

18.11.4 RECENT DEVELOPMENTS

18.12 MIRACLEAN TECHNOLOGY CO.,LTD.

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENT

18.13 OASIS DIAGNOSTICS CORPORATION

18.13.1 COMPANY SNAPSHOT

18.13.2 PRODUCT PORTFOLIO

18.13.3 RECENT DEVELOPMENT

18.14 PERIRX

18.14.1 COMPANY SNAPSHOT

18.14.2.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 SALIMETRICS, LLC

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 SARSTEDT AG & CO. KG

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENT

18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)

18.17.1 COMPANY SNAPSHOT

18.17.2 REVENUE ANALYSIS

18.17.3 PRODUCT PORTFOLIO

18.17.4 RECENT DEVELOPMENTS

18.18 THERMO FISHER SCIENTIFIC INC.

18.18.1 COMPANY SNAPSHOT

18.18.2 REVENUE ANALYSIS

18.18.3 PRODUCT PORTFOLIO

18.18.4 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

表格列表

LIST OF TABLES 

TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.

TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.

TABLE 3 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 50 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 54 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 55 U.S. CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 U.S. SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 57 U.S. CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 58 U.S. CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 U.S. CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 60 U.S. CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 61 U.S. CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 U.S. CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 63 CANADA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 CANADA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 65 CANADA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 66 CANADA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 CANADA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 68 CANADA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 69 CANADA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 CANADA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 MEXICO CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 MEXICO SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 73 MEXICO CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 74 MEXICO CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 MEXICO CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 76 MEXICO CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 77 MEXICO CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 MEXICO CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

图片列表

LIST OF FIGURES 

FIGURE 1 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION

FIGURE 2 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS

FIGURE 4 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION

FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE NORTH AMERICA CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 SALVIA COLLECTION KIT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CANCER SPIT TEST DEVICES MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA CANCER SPIT TEST DEVICES MARKET

FIGURE 14 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES

FIGURE 15 ESTIMATED AGE-STANDARDIZED INCIDENCE RATES (WORLD) IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES

FIGURE 16 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2020

FIGURE 17 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 18 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 19 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2020

FIGURE 21 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2021-2028 (USD MILLION)

FIGURE 22 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, CAGR (2021-2028)

FIGURE 23 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, LIFELINE CURVE

FIGURE 24 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2020

FIGURE 25 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 26 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 27 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 28 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2020

FIGURE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2021-2028 (USD MILLION)

FIGURE 30 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, CAGR (2021-2028)

FIGURE 31 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 32 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2020

FIGURE 33 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2021-2028 (USD MILLION)

FIGURE 34 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, CAGR (2021-2028)

FIGURE 35 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, LIFELINE CURVE

FIGURE 36 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, 2020

FIGURE 37 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, 2021-2028 (USD MILLION)

FIGURE 38 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, CAGR (2021-2028)

FIGURE 39 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: END USER, LIFELINE CURVE

FIGURE 40 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 42 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 43 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: SNAPSHOT (2020)

FIGURE 45 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020)

FIGURE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)

 

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.